Pharmanutra S.p.A. (BIT:PHN)
52.30
-1.40 (-2.61%)
May 13, 2025, 5:35 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Direct | 63.56M |
Log In |
Log In |
Log In |
Log In |
Direct Growth | 10.56% |
Log In |
Log In |
Log In |
Log In |
Indirect | 31.61M |
Log In |
Log In |
Log In |
Log In |
Indirect Growth | 35.83% |
Log In |
Log In |
Log In |
Log In |
Akern | 5.03M |
Log In |
Log In |
Log In |
Log In |
Akern Growth | 156.50% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Italy | 67.98M |
Log In |
Log In |
Log In |
Log In |
Italy Growth | 14.76% |
Log In |
Log In |
Log In |
Log In |
Europe | 16.89M |
Log In |
Log In |
Log In |
Log In |
Europe Growth | 29.77% |
Log In |
Log In |
Log In |
Log In |
Middle East | 10.61M |
Log In |
Log In |
Log In |
Log In |
Middle East Growth | 35.44% |
Log In |
Log In |
Log In |
Log In |
South America | 1.95M |
Log In |
Log In |
Log In |
Log In |
Far East | 1.55M |
Log In |
Log In |
Log In |
Log In |
Far East Growth | 84.09% |
Log In |
Log In |
Log In |
Log In |
Other | 1.23M |
Log In |
Log In |
Log In |
Log In |
Other Growth | 53.24% |
Log In |
Log In |
Log In |
Log In |
Africa | - |
Log In |
Log In |
Log In |
Log In |
Africa Growth | - |
Log In |
Log In |
Log In |
Log In |